Advertisement

Index by author

May 01, 1992; Volume 41,Issue 5

  1. D'santos, C S

    1. Stimulation of adenylate cyclase by amylin in CHO-K1 cells.
      C S D'Santos, A Gatti, D R Poyner and M R Hanley
      Molecular Pharmacology May 1992, 41 (5) 894-899;

  2. Debyser, Z

    1. Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.
      Z Debyser, R Pauwels, M Baba, J Desmyter and E De Clercq
      Molecular Pharmacology May 1992, 41 (5) 963-968;

  3. De Clercq, E

    1. Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.
      Z Debyser, R Pauwels, M Baba, J Desmyter and E De Clercq
      Molecular Pharmacology May 1992, 41 (5) 963-968;

  4. Degray, J A

    1. Free radical metabolism of halothane in vivo: radical adducts detected in bile.
      K T Knecht, J A DeGray and R P Mason
      Molecular Pharmacology May 1992, 41 (5) 943-949;

  5. Desmyter, J

    1. Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.
      Z Debyser, R Pauwels, M Baba, J Desmyter and E De Clercq
      Molecular Pharmacology May 1992, 41 (5) 963-968;

  6. Domin, B A

    1. Membrane permeation characteristics of 5'-modified thymidine analogs.
      B A Domin, W B Mahony, G W Koszalka, D J Porter, G Hajian and T P Zimmerman
      Molecular Pharmacology May 1992, 41 (5) 950-956;

  7. Donald, A E

    1. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
      A C Foster, J A Kemp, P D Leeson, S Grimwood, A E Donald, G R Marshall, T Priestley, J D Smith and R W Carling
      Molecular Pharmacology May 1992, 41 (5) 914-922;

  8. Eva, C

    1. Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor.
      J Krause, C Eva, P H Seeburg and R Sprengel
      Molecular Pharmacology May 1992, 41 (5) 817-821;

  9. Evans, J F

    1. Characterization of a 5-lipoxygenase-activating protein binding assay: correlation of affinity for 5-lipoxygenase-activating protein with leukotriene synthesis inhibition.
      S Charleson, P Prasit, S Léger, J W Gillard, P J Vickers, J A Mancini, P Charleson, J Guay, A W Ford-Hutchinson and J F Evans
      Molecular Pharmacology May 1992, 41 (5) 873-879;

  10. Fleming, C M

    1. Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4.
      C M Fleming, R A Branch, G R Wilkinson and F P Guengerich
      Molecular Pharmacology May 1992, 41 (5) 975-980;
« Previous (Pages : 1 2 3 4 5 6 7 8 ... 11) Next »
Back to top

In this issue

Advertisement